METTL7A is a potential biomarker for the diagnosis and prognosis of acute myeloid leukemia
High METTL7A expression is associated with poor prognosis in AML and may be a potential diagnostic and prognostic biomarker.
Authors
- Yuanyuan Tan (ORCID: https://orcid.org/0009-0006-7550-5769)
- Jiajia Li (ORCID: https://orcid.org/0000-0003-4694-0789)
- TingTing Zhang (ORCID: https://orcid.org/0009-0005-4670-3603)
- Zhibin Xie (ORCID: https://orcid.org/0009-0004-5981-687X)
- Meng Wang (ORCID: https://orcid.org/0009-0005-4676-7682)
- Meng-Meng Zhang (ORCID: https://orcid.org/0009-0000-3993-5821)
Institutions
- Bengbu Medical College (CN)
- First Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1080/16078454.2025.2535882
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00